Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2002

Study Completion Date

July 31, 2006

Conditions

Breast Cancer

Interventions

DRUG

tamoxifen citrate

DRUG

tipifarnib

Trial Locations (2)

NCI - Center for Cancer Research, Bethesda

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00052728 - Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter